European Research Advisory Board

Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief Executive Officer of PTC Therapeutics

Retrieved on: 
Friday, March 24, 2023
Yale University, Mitochondrion, PTC Therapeutics, Drug development, University, Gene, The Conference Board, Conference call, PTC, Cancer, Eladocagene exuparvovec, Coronavirus Scientific Advisory Board, European Research Advisory Board, Brain, CMO, RNA, History, CNS, DSM-IV codes, EMA, Bachelor of Arts in Clinical Psychology, Biosensors and Bioelectronics, Shriners Hospitals for Children, ET, Retirement, Oxidative stress, Consultant, Patient, University of Washington Department of Global Health, Stuart, Growth, Mitochondrial disease, Rare, Therapy, Scientific Advisory Group for Emergencies, Conference, Stu, Management, Pharmaceutical industry, Vaccine, Nursing

SOUTH PLAINFIELD, N.J., March 24, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT). Stuart Peltz, Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years. Dr. Peltz has led PTC Therapeutics as its CEO since its founding in 1998 and pioneered the field of RNA-directed drug development. Under his leadership, PTC has grown from a research organization with expertise in the control of RNA processes to a publicly traded, integrated, global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for the treatment of neurological and neuromuscular disorders, metabolic disorders, and cancer.

Key Points: 
  • Stuart Peltz, Ph.D., founding Chief Executive Officer (CEO) of PTC Therapeutics announced today that he is stepping down after 25 years.
  • Dr. Peltz has led PTC Therapeutics as its CEO since its founding in 1998 and pioneered the field of RNA-directed drug development.
  • What Stuart and the team have achieved in 25 years is extraordinary," said Michael Schmertzler, Chairman of the Board of Directors.
  • Matthew Klein, M.D., M.S., F.A.C.S., current Chief Operating Officer, has been named the company's CEO and will join the Board of Directors.

Daiwa Securities Group holds first place in the leaders’ table as this year’s top research provider for Japan

Retrieved on: 
Monday, March 13, 2023
Acquisition, European Research Advisory Board, J. P. Morgan, Citigroup, Daiwa Securities Group, Mizuho, Research, Mizuho Securities, Marketing, SMBC Nikko Securities, Retail, Cryptocurrency, Nomura

Performance analysis on the data output allows in-depth comparative analytics which can be used for strategic business decision-making.

Key Points: 
  • Performance analysis on the data output allows in-depth comparative analytics which can be used for strategic business decision-making.
  • The Japan Research survey’s increasing influence was highlighted by another increase in the number of active participants: over 1,000 portfolio managers and analysts at 432 institutions, up from 422 the previous year.
  • The leading firms include Daiwa Securities Group with 32 published analyst positions (34 last year), Mizuho Securities with 27 (no change) and SMBC Nikko Securities with 21 (down from 26 last year) in third place.
  • To share your position on your website content, advertisements, communications and marketing collateral, please contact [email protected].

Institutional Investor Publishes 2022 All-America Research Team Rankings

Retrieved on: 
Tuesday, October 25, 2022
J. P. Morgan, Appetite, EMEA, Efficiency, Emerging, RBC, Shaun Ellis (wolf researcher), Barclays, Research, Credit Suisse, Bank of America, Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder (CREST.BD), II, Capital, Wells Fargo, Acquisition, Institutional Investor, Marketing, BofA Securities, Industry, UBS, Morgan Stanley, GLOBE, Environment, Jefferies, European Research Advisory Board, Retail, Pharmaceutical industry

NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Institutional Investor Research (II Research) surveys are the leading provider of market sentiment in the financial industry.

Key Points: 
  • NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Institutional Investor Research (II Research) surveys are the leading provider of market sentiment in the financial industry.
  • Research activity has been restored following the Covid pandemic, with analysts starting to market again at similar levels to pre-pandemic.
  • For the seventh year in a row, J.P. Morgan claims first place in the Research Team leaders table with 47 published positions.
  • Esther Weisz, Director II Research, says, Despite a mixed economic backdrop, the demand for high quality research remains high.

Hospitality Technology Announces its 2022 Top Women in Restaurant Technology Award Winners and its Industry Hero Award Winners

Retrieved on: 
Thursday, March 17, 2022
Face, Trust, China Hospitality Technology Alliance, Information technology, Draughts, European Research Advisory Board, APAC, Leadership, Glass, Marketing, Restaurant, Growth, Pollo Campero, Amazon Web Services, Program, Woman, Data mining, Conference, Achievement, Checkers and Rally's, CEO, Senior, Entrepreneurship, HT, Technology, Industry, Jollibee, ESIEE Paris, Final good, EMEA, Burger King, AWS, Neiman, Presto (restaurant technology platform), Inspire Brands, Management, Auction, Food industry, Online shopping, Food delivery

Hospitality Technology (HT) magazine is pleased to announce the winners of its 2022 Top Women in Restaurant Technology Awards.

Key Points: 
  • Hospitality Technology (HT) magazine is pleased to announce the winners of its 2022 Top Women in Restaurant Technology Awards.
  • "The Top Women in Restaurant Technology awards program celebrates the achievements of women across a diversity of career levels and roles in our industry," says Robert Firpo-Cappiello, editor-in-chief of Hospitality Technology magazine.
  • The Industry Heroes Awards recognize both restaurants and technology suppliers for exemplary contributions to the restaurant industry during the pandemic.
  • Top Women in Restaurant Technology Award winners and Industry Heroes were chosen by Hospitality Technology magazine and members of its Research Advisory Board.

Institutional Investor Launches 2022 Japan Research Rankings

Retrieved on: 
Monday, March 14, 2022
Institution, Research, European Research Advisory Board, Acquisition, GLOBE, SMBC, J. P. Morgan, Mitsubishi, Institutional Investor, Morgan Stanley, Mizuho Securities, Daiwa Securities Group, Industry, Mizuho, Marketing, Renewable energy, Public relations, Nomura, Mother of All Asia–Tower of Peace

TOKYO, March 14, 2022 (GLOBE NEWSWIRE) -- The Institutional Investor Japan Research survey determines the best-in-class of sell-side research teams and provides valuable qualitative market feedback from market participants on optimising the provision, acquisition and consumption of Research Advisory services across Japan.

Key Points: 
  • TOKYO, March 14, 2022 (GLOBE NEWSWIRE) -- The Institutional Investor Japan Research survey determines the best-in-class of sell-side research teams and provides valuable qualitative market feedback from market participants on optimising the provision, acquisition and consumption of Research Advisory services across Japan.
  • In addition, Institutional Investor offers highly-respected proprietary benchmark research and rankings.
  • Institutional Investor Research provides independent sell-side and corporate performance research and rankings and aims to be the first-choice and independent validation source of qualitative market intelligence for all three sides of the investment community.
  • Institutional Investor Research has a global presence, spanning Europe, All-Asia, the US and Latin America.

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

Retrieved on: 
Thursday, February 24, 2022
Psilocybin, DEA, Disorder, Reperfusion injury, Use, COVID-19, University, Therapy, Company, OTC, Mental health, Purchasing, University of Wisconsin–Madison, Health, Research, CSE, Organization, Drug development, Food, RVV, Substance-related disorder, Orphan drug, FSE, Contract research organization, III, European Research Advisory Board, Addiction, Export, Technology, Patient, CRO, GMP, Ischemia, Hydra, API, Delivery, Autoimmune hepatitis, Inflammation, Acquisition, Liver disease, Science, News, Infection, FDA, Cancer, Organ transplantation, Cros, Pharmaceutical industry, 3D printing, BC, CBD, Revive

"We are so pleased to be able to supply our naturally derived, GMP psilocybin for this potentially ground-breaking research related to addiction disorders," says HAVN Life CEO Tim Moore.

Key Points: 
  • "We are so pleased to be able to supply our naturally derived, GMP psilocybin for this potentially ground-breaking research related to addiction disorders," says HAVN Life CEO Tim Moore.
  • "We are excited to work with HAVN Life to move forward with our investigational clinical trials including our project in Antigua", says Revive CEO Michael Frank.
  • "We wish Revive Therapeutics and The University of Wisconsin-Madison continued success as they further progress their clinical trials investigation treatments," he adds.
  • Revive Therapeutic Ltd. is a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases.

HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market

Retrieved on: 
Thursday, February 17, 2022
API, Patient, Technology, Cancer, Food, Health, Company, Chad, III, OTC, GMP, Drug, Mental health, FSE, Therapy, FDA, DEA, Partnership, Philippine Drug Enforcement Agency, Agreement, CSE, Research, Psilocybin, News, European Research Advisory Board, II, Pharmaceutical industry, 3D printing, BC

HAVN Life and Mycrodose have entered into the Exclusive Distribution Agreement to facilitate the import of HAVN Life's naturally derived GMP psilocybin into the United States for authorized research purposes.

Key Points: 
  • HAVN Life and Mycrodose have entered into the Exclusive Distribution Agreement to facilitate the import of HAVN Life's naturally derived GMP psilocybin into the United States for authorized research purposes.
  • "HAVN Life is kicking off 2022 with strong partnerships in both our research and retail divisions, and we are very excited to start fulfilling purchase orders for our research customers with our new U.S. distribution partner, Mycrodose Therapeutics," says HAVN Life CEO, Tim Moore.
  • In December 2021, Mycrodose added a Schedule I Import license which allows the import of Schedule I psilocybin and psilocin.
  • HAVN Life offers a full range of high-quality mushroom and plant extracts that help support immune function and support a healthy lifestyle.

HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market

Retrieved on: 
Thursday, February 10, 2022
News, DEA, FSE, Drug, Health, OTC, III, CSE, Philippine Drug Enforcement Agency, Technology, Research, Mental health, Company, Cancer, GMP, Chad, Agreement, Therapy, API, II, FDA, Patient, Psilocybin, Food, Partnership, European Research Advisory Board, Pharmaceutical industry, 3D printing, BC

HAVN Life and Mycrodose have entered into the Exclusive Distribution Agreement to facilitate the import of HAVN Life's naturally derived GMP psilocybin into the United States for authorized research purposes.

Key Points: 
  • HAVN Life and Mycrodose have entered into the Exclusive Distribution Agreement to facilitate the import of HAVN Life's naturally derived GMP psilocybin into the United States for authorized research purposes.
  • "HAVN Life is kicking off 2022 with strong partnerships in both our research and retail divisions, and we are very excited to start fulfilling purchase orders for our research customers with our new U.S. distribution partner, Mycrodose Therapeutics," says HAVN Life CEO, Tim Moore.
  • In December 2021, Mycrodose added a Schedule I Import license which allows the import of Schedule I psilocybin and psilocin.
  • HAVN Life offers a full range of high-quality mushroom and plant extracts that help support immune function and support a healthy lifestyle.

Hospitality Technology Seeks Nominations for 2022 Top Women in Restaurant Technology Awards, Industry Heroes

Retrieved on: 
Friday, January 7, 2022
Restaurant, Presto (restaurant technology platform), HT, Industry, Program, European Research Advisory Board, Technology, Woman, APAC, Glass, Neiman, Social media, RTN, Conference, Information technology, Jollibee, Systematic Paris-Region, Chicago Franchise Systems, Inc., China Hospitality Technology Alliance, Pollo Campero, Summer, Marketing, EMEA, Burger King, Data mining, Leadership, Food delivery, Management

CHICAGO, Jan. 7, 2022 /PRNewswire-PRWeb/ --Hospitality Technology (HT) magazine is pleased to announce that it is accepting nominations for the sixth annual Top Women in Restaurant Technology Awards and the Industry Heroes, now in their second year.

Key Points: 
  • CHICAGO, Jan. 7, 2022 /PRNewswire-PRWeb/ --Hospitality Technology (HT) magazine is pleased to announce that it is accepting nominations for the sixth annual Top Women in Restaurant Technology Awards and the Industry Heroes, now in their second year.
  • Sponsored by Tillster, the Top Women in Restaurant Technology Awards will recognize and honor a diverse array of females in the restaurant technology industry, including restaurant companies and technology providers.
  • "The Top Women in Restaurant Technology awards program celebrates the achievements of women across a diversity of career levels and roles in our industry," says Robert Firpo-Cappiello, editor-in-chief of Hospitality Technology magazine.
  • Submit your 2022 Top Women in Restaurant Technology nominations here: https://forms.gle/BzWGZCEU2ucdmmrm7
    The deadline for nominations is January 12, 2022.

Institutional Investor Publishes 2021 All-America Research Team Rankings

Retrieved on: 
Tuesday, October 26, 2021
Well, European Research Advisory Board, Shaun Ellis (wolf researcher), BofA Securities, Research, Efficiency, Capital, Barclays, Industry, Travel, Collaborative RESearch Team to study psychosocial issues in Bipolar Disorder (CREST.BD), UBS, II, ESG, Â, Wells Fargo, Institutional Investor, Morgan Stanley, Jefferies, Appetite, Marketing, Pressure, J. P. Morgan, Asia, Bank of America, EMEA, Environment, Institution, Emerging, Acquisition, Citigroup, GLOBE, Credit Suisse, Neck, Retail, Video game console

NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) -- 50th year Anniversary of America Research - The Institutional Investor (II) All-America Research survey celebrates 50 years of ranking the top analysts in Americas broking industry, the first research survey to be published at Institutional Investor.

Key Points: 
  • NEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) -- 50th year Anniversary of America Research - The Institutional Investor (II) All-America Research survey celebrates 50 years of ranking the top analysts in Americas broking industry, the first research survey to be published at Institutional Investor.
  • However, the quantity and quality of written research has increased exponentially, contributing to an acutely competitive equity research market.
  • For the sixth year in a row, J.P. Morgan claims first place in the Research Team leaders table with 49 published positions.
  • We are delighted, in 2021, to be celebrating 50 years of Institutional Investor rankings in All-America and we look forward to celebrating the success of those top-ranked firms and analysts in this milestone year.